MLH1 and ovarian cancer: Similarly, most of MSI/dMMR gastric cancers, ovarian cancers, and ampullary carcinomas with a loss of MLH1 expression are associated with MLH1 promoter hypermethylation, suggesting sporadic cancers [56,76,256,257].